v3.26.1
GOODWILL AND INTANGIBLE ASSETS - Narrative (Details)
$ in Thousands
 1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Mar. 31, 2026
USD ($)
Dec. 29, 2025
USD ($)
Nov. 20, 2025
USD ($)
Nov. 06, 2025
USD ($)
netSaleAchievment
contingentMilestone
Dec. 29, 2025
USD ($)
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
Dec. 31, 2025
USD ($)
Jul. 01, 2025
USD ($)
Intangible Asset, Indefinite-Lived, Acquired [Line Items]                      
Goodwill           $ 24,681   $ 24,681   $ 24,681  
Contingent consideration           1,000   1,000   2,200  
Intangible assets, net           37,397   37,397   39,470  
Amortization of intangible assets           1,043 $ 0 2,074 $ 0    
Xepi                      
Intangible Asset, Indefinite-Lived, Acquired [Line Items]                      
Intangible assets, net           5,449   5,449      
Amended Sato license                      
Intangible Asset, Indefinite-Lived, Acquired [Line Items]                      
Intangible assets, net           502   $ 502      
Impairment of intangible assets                   285  
Ferrer Internacional, S. A. & Interquim, S. A. U. | Ferrer License Agreement                      
Intangible Asset, Indefinite-Lived, Acquired [Line Items]                      
License and supply agreement, purchase obligation, forecast period       24 months              
License and supply agreement, binding forecast period       8 months              
License and supply agreement, purchase requirement, percentage       100.00%              
License and supply agreement, initial term       12 years              
License and supply agreement, renewal term       1 year              
License and supply agreement, notice of termination, minimum period before end of term       3 months              
Upfront payment payable $ 1,200     $ 1,200              
Upfront payment           1,200          
Payments for initial supply           456          
Percent royalty based on net sales       7.00%              
License and supply agreement, initial supply amount $ 456     $ 456   $ 456          
Biofrontera                      
Intangible Asset, Indefinite-Lived, Acquired [Line Items]                      
Upfront Payment - Asset Purchase Agreement       $ 3,000              
Contingent consideration, number of milestone payments | contingentMilestone       2              
Contingent consideration, number of net sales achievements | netSaleAchievment       2              
Biofrontera | Contingent Consideration - Achievement of Commercial Quantities                      
Intangible Asset, Indefinite-Lived, Acquired [Line Items]                      
Consideration to be transferred, contingent consideration       $ 1,000              
Biofrontera | Contingent Consideration - Achievement of Sales Based Milestones                      
Intangible Asset, Indefinite-Lived, Acquired [Line Items]                      
Consideration to be transferred, contingent consideration       3,000              
Xepi Transaction                      
Intangible Asset, Indefinite-Lived, Acquired [Line Items]                      
Contingent consideration       $ 2,200           2,200  
Xepi Transaction | Contractual Amount                      
Intangible Asset, Indefinite-Lived, Acquired [Line Items]                      
Consideration transferred                   12,080  
Xepi Transaction | Xepi                      
Intangible Asset, Indefinite-Lived, Acquired [Line Items]                      
Remaining Useful Life (Years)       6 years              
Xepi Transaction | Contingent Consideration - Acceptance of Initial API Purchase | Ferrer | Contractual Amount                      
Intangible Asset, Indefinite-Lived, Acquired [Line Items]                      
Contingent consideration       $ 1,200           $ 1,200  
XEGLYZE Asset Purchase Agreement                      
Intangible Asset, Indefinite-Lived, Acquired [Line Items]                      
Upfront Payment - Asset Purchase Agreement   $ 1,350 $ 450   $ 1,800            
Consideration transferred         1,817            
Xepi Transaction - Transaction Expenses         $ 17            
XEGLYZE Asset Purchase Agreement | Intellectual Property                      
Intangible Asset, Indefinite-Lived, Acquired [Line Items]                      
Remaining Useful Life (Years)   9 years     9 years            
Maximum | Biofrontera                      
Intangible Asset, Indefinite-Lived, Acquired [Line Items]                      
Asset acquisition, price of acquisition, expected       $ 10,000              
LNHC, Inc.                      
Intangible Asset, Indefinite-Lived, Acquired [Line Items]                      
Goodwill                     $ 24,681
Goodwill, expected tax deductible, amount                     $ 0